Delivery Order SPE2DX22D0010-SPE2D825FGH67
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $4,848.20 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for AZSTARYS capsules (39.2mg/7.8mg), a prescription medication used in the treatment of attention-deficit/hyperactivity disorder. This firm fixed price, non-set-aside contract is scheduled for completion by September 12, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single...
- On September 10, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,414.27 to AmerisourceBergen Drug Corp for Azstarys capsules (52.3mg/10.4mg), a prescription medication used in the treatment of attention deficit hyperactivity disorder. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The work will be performed at the contractor's corporate office location in Conshohocken,...
- This is a firm-fixed-price delivery order for $3,808.23 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AZSTARYS capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is not set aside and does not appear to be associated with a larger contract vehicle. The delivery order has an ultimate completion date of June 23, 2025....
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,719.10 to AmerisourceBergen Drug Corp for AZSTARYS 26.1 mg-5.2 mg capsules (100-count package) on March 5, 2025. This competitive award, which carries an ultimate completion date of March 6, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,034.80 by the Defense Logistics Agency (DLA) on September 9, 2025, with completion expected by September 10, 2025. The contract, issued under a firm fixed-price arrangement with no set-aside designation, calls for the delivery of Azstarys 39.2 mg-7.8 mg capsules (100-count units), a prescription medication used to treat...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,921.48 to AmerisourceBergen Drug Corp for 100 capsules of AZSTARYS 26.1 mg-5.2 mg, a prescription medication. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 9, 2025. This delivery order represents a child contract under...
- This is a $1,797.13 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product, with a performance period ending on May 22, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a $1,304.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product, with a performance period ending on February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,277.09, is for the provision of AZSTARYS CAPS 52.3MG/10.4MG, a pharmaceutical product. The award has an ultimate completion date of January 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $2,959.88 contract is for the delivery of the medication AZSTARYS CAPS 39.2MG/7.8MG. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which runs through December 2026. This IDC serves as a comprehensive global...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FGH67Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $2,046.80 on June 16, 2025, with an ultimate completion date of June 17, 2025. This competitively awarded, firm fixed-price delivery order covers the supply of AZSTARYS Capsules (39.2mg/7.8mg), a prescription medication used for attention deficit hyperactivity disorder treatment. No set-aside designation was applied to this contract. The vendor, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company maintains a significant role in federal pharmaceutical procurement, regularly fulfilling competitively awarded delivery orders for specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 6/16/25 |